Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SSRI sexual dysfunction: a female perspective.

Paula L Hensley1, H George Nurnberg

  • 1Department of Psychiatry, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.

Journal of Sex & Marital Therapy
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening for Depression Through a Glass Darkly.

JAMA internal medicine·2017
Same author

Randomized controlled trials of olanzapine treatment of borderline personality disorder: two similar studies with different results.

The Journal of clinical psychiatry·2011
Same author

Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.

JAMA·2008
Same author

Escitalopram: an open-label study of bereavement-related depression and grief.

Journal of affective disorders·2008
Same author

An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction.

Drugs of today (Barcelona, Spain : 1998)·2008
Same author

Primary sexual disorders: recognition and treatment.

Psychopharmacology bulletin·2008
Same journal

The Effect of Spousal Support on Sexual Quality of Life and Psychological Well-Being Among Menopausal Women.

Journal of sex & marital therapy·2026
Same journal

Translation, cross-cultural adaptation, and validation of the Vulvar Pain Assessment Questionnaire (VPAQscreen) for Brazilian Portuguese.

Journal of sex & marital therapy·2026
Same journal

Sexual self-schemas across midlife: examining differences using computerized text analysis.

Journal of sex & marital therapy·2026
Same journal

Female Sexual Dysfunction Across Diabetes Types Compared to Non-Diabetic Controls: A Systematic Review and Meta-Analysis.

Journal of sex & marital therapy·2026
Same journal

Sexual Inhibition Moderates Associations Between Coerced Unwanted Sexual Contact and College Women's BDSM Fantasies.

Journal of sex & marital therapy·2026
Same journal

Correction.

Journal of sex & marital therapy·2026
See all related articles

Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed, but can cause sexual dysfunction. While men report higher rates, women experience more severe SSRI-related sexual side effects, with sildenafil offering a potential treatment.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Women's Health

Background:

  • Women have higher depression rates than men.
  • Selective serotonin reuptake inhibitors (SSRIs) treat various conditions, some more prevalent in women.
  • SSRIs are associated with sexual side effects, impacting treatment adherence and quality of life.

Purpose of the Study:

  • To review the epidemiology of sexual dysfunction associated with SSRI use.
  • To discuss the prevalence and severity of sexual side effects in women taking SSRIs.
  • To explore sildenafil as a potential treatment for SSRI-induced sexual dysfunction.

Main Methods:

  • Literature review of epidemiological studies on SSRI-induced sexual dysfunction.
  • Analysis of reported sexual side effect rates and severity in men and women.

Related Experiment Videos

  • Examination of clinical data regarding sildenafil efficacy for sexual dysfunction.
  • Main Results:

    • Women experience depression at 2-3 times the rate of men.
    • While men report higher incidence of sexual side effects from SSRIs, women report greater severity.
    • Sildenafil is presented as a treatment option for SSRI-induced sexual dysfunction.

    Conclusions:

    • SSRI-induced sexual dysfunction is a significant concern, particularly for women.
    • The severity of sexual dysfunction in women warrants further investigation and targeted treatment strategies.
    • Sildenafil demonstrates potential as a therapeutic intervention for managing SSRI-related sexual dysfunction in women.